These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 18332429)

  • 21. EndoSd: an IgG glycan hydrolyzing enzyme in Streptococcus dysgalactiae subspecies dysgalactiae.
    Shadnezhad A; Naegeli A; Sjögren J; Adamczyk B; Leo F; Allhorn M; Karlsson NG; Jensen A; Collin M
    Future Microbiol; 2016 Jun; 11():721-36. PubMed ID: 27200457
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EndoS2 is a unique and conserved enzyme of serotype M49 group A Streptococcus that hydrolyses N-linked glycans on IgG and α1-acid glycoprotein.
    Sjögren J; Struwe WB; Cosgrave EF; Rudd PM; Stervander M; Allhorn M; Hollands A; Nizet V; Collin M
    Biochem J; 2013 Oct; 455(1):107-18. PubMed ID: 23865566
    [TBL] [Abstract][Full Text] [Related]  

  • 23. EndoS and SpeB from Streptococcus pyogenes inhibit immunoglobulin-mediated opsonophagocytosis.
    Collin M; Svensson MD; Sjöholm AG; Jensenius JC; Sjöbring U; Olsén A
    Infect Immun; 2002 Dec; 70(12):6646-51. PubMed ID: 12438337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single molecule Förster resonance energy transfer studies of the effect of EndoS deglycosylation on the structure of IgG.
    Piraino MS; Kelliher MT; Aburas J; Southern CA
    Immunol Lett; 2015 Sep; 167(1):29-33. PubMed ID: 26112419
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IdeS: a bacterial proteolytic enzyme with therapeutic potential.
    Johansson BP; Shannon O; Björck L
    PLoS One; 2008 Feb; 3(2):e1692. PubMed ID: 18301769
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanism of antibody-specific deglycosylation and immune evasion by Streptococcal IgG-specific endoglycosidases.
    Trastoy B; Du JJ; Cifuente JO; Rudolph L; García-Alija M; Klontz EH; Deredge D; Sultana N; Huynh CG; Flowers MW; Li C; Sastre DE; Wang LX; Corzana F; Mallagaray A; Sundberg EJ; Guerin ME
    Nat Commun; 2023 Mar; 14(1):1705. PubMed ID: 36973249
    [TBL] [Abstract][Full Text] [Related]  

  • 27. EndoS and EndoS2 hydrolyze Fc-glycans on therapeutic antibodies with different glycoform selectivity and can be used for rapid quantification of high-mannose glycans.
    Sjögren J; Cosgrave EF; Allhorn M; Nordgren M; Björk S; Olsson F; Fredriksson S; Collin M
    Glycobiology; 2015 Oct; 25(10):1053-63. PubMed ID: 26156869
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extensive substrate recognition by the streptococcal antibody-degrading enzymes IdeS and EndoS.
    Sudol ASL; Butler J; Ivory DP; Tews I; Crispin M
    Nat Commun; 2022 Dec; 13(1):7801. PubMed ID: 36528711
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo enzymatic modulation of IgG glycosylation inhibits autoimmune disease in an IgG subclass-dependent manner.
    Albert H; Collin M; Dudziak D; Ravetch JV; Nimmerjahn F
    Proc Natl Acad Sci U S A; 2008 Sep; 105(39):15005-9. PubMed ID: 18815375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dominant suppression of inflammation by glycan-hydrolyzed IgG.
    Nandakumar KS; Collin M; Happonen KE; Croxford AM; Lundström SL; Zubarev RA; Rowley MJ; Blom AM; Holmdahl R
    Proc Natl Acad Sci U S A; 2013 Jun; 110(25):10252-7. PubMed ID: 23671108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo enzymatic modulation of IgG antibodies prevents immune complex-dependent skin injury.
    Mihai S; Albert H; Ludwig RJ; Iwata H; Björck L; Collin M; Nimmerjahn F
    Exp Dermatol; 2017 Aug; 26(8):691-696. PubMed ID: 27512946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endoglycosidase treatment abrogates IgG arthritogenicity: importance of IgG glycosylation in arthritis.
    Nandakumar KS; Collin M; Olsén A; Nimmerjahn F; Blom AM; Ravetch JV; Holmdahl R
    Eur J Immunol; 2007 Oct; 37(10):2973-82. PubMed ID: 17899548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glycosylation of autoantibodies: insights into the mechanisms of immune thrombocytopenia.
    Bakchoul T; Walek K; Krautwurst A; Rummel M; Bein G; Santoso S; Sachs UJ
    Thromb Haemost; 2013 Dec; 110(6):1259-66. PubMed ID: 24067937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An endoglycosidase with alternative glycan specificity allows broadened glycoprotein remodelling.
    Goodfellow JJ; Baruah K; Yamamoto K; Bonomelli C; Krishna B; Harvey DJ; Crispin M; Scanlan CN; Davis BG
    J Am Chem Soc; 2012 May; 134(19):8030-3. PubMed ID: 22551167
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The protective effect of immunoglobulin in murine tuberculosis is dependent on IgG glycosylation.
    Olivares N; Marquina B; Mata-Espinoza D; Zatarain-Barron ZL; Pinzón CE; Estrada I; Parada C; Collin M; Rook G; Hernandez-Pando R
    Pathog Dis; 2013 Dec; 69(3):176-83. PubMed ID: 23873753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Can antibodies with specificity for soluble antigens mimic the therapeutic effects of intravenous IgG in the treatment of autoimmune disease?
    Siragam V; Brinc D; Crow AR; Song S; Freedman J; Lazarus AH
    J Clin Invest; 2005 Jan; 115(1):155-60. PubMed ID: 15630455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Streptococcal Endo-β-
    Nandakumar KS; Collin M; Happonen KE; Lundström SL; Croxford AM; Xu B; Zubarev RA; Rowley MJ; Blom AM; Kjellman C; Holmdahl R
    Front Immunol; 2018; 9():1623. PubMed ID: 30061892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural basis for the recognition of complex-type N-glycans by Endoglycosidase S.
    Trastoy B; Klontz E; Orwenyo J; Marina A; Wang LX; Sundberg EJ; Guerin ME
    Nat Commun; 2018 May; 9(1):1874. PubMed ID: 29760474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endoglycosidase S Enables a Highly Simplified Clinical Chemistry Procedure for Direct Assessment of Serum IgG Undergalactosylation in Chronic Inflammatory Disease.
    Vanderschaeghe D; Meuris L; Raes T; Grootaert H; Van Hecke A; Verhelst X; Van de Velde F; Lapauw B; Van Vlierberghe H; Callewaert N
    Mol Cell Proteomics; 2018 Dec; 17(12):2508-2517. PubMed ID: 30190373
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insights into substrate recognition and specificity for IgG by Endoglycosidase S2.
    Aytenfisu AH; Deredge D; Klontz EH; Du J; Sundberg EJ; MacKerell AD
    PLoS Comput Biol; 2021 Jul; 17(7):e1009103. PubMed ID: 34310592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.